Other

Cash flow hedges

West Pharmaceutical Services Cash flow hedges increased by 35.3% to -$1.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 164.7%, from $1.70M to -$1.10M.

Analysis

StatementIncome Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ3 2023
Last reportedQ1 2026Apr 23, 2026

How to read this metric

Fluctuations indicate the effectiveness of the company's hedging strategy in managing market volatility and protecting future cash flows.

Detailed definition

This metric tracks the gains or losses recognized in other comprehensive income resulting from the effective portion of...

Peer comparison

Standardized reporting for companies utilizing derivatives to manage financial risk exposure.

Metric ID: other_other_comprehensive_income_loss_cash_flow_hedge_ga_aa440c

Historical Data

8 periods
 Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value-$2.00M-$2.80M-$3.70M$5.50M$1.70M$2.20M-$1.70M-$1.10M
QoQ Change-40.0%-32.1%+248.6%-69.1%+29.4%-177.3%+35.3%
YoY Change+375.0%+160.7%+159.5%-130.9%-164.7%
Range-$3.70M$5.50M
CAGR-28.9%
Avg YoY Growth+79.9%
Median YoY Growth+159.5%

Frequently Asked Questions

What is West Pharmaceutical Services's cash flow hedges?
West Pharmaceutical Services (WST) reported cash flow hedges of -$1.10M in Q1 2026.
How has West Pharmaceutical Services's cash flow hedges changed year-over-year?
West Pharmaceutical Services's cash flow hedges decreased by 164.7% year-over-year, from $1.70M to -$1.10M.
What does cash flow hedges mean?
The net gain or loss from financial instruments used to hedge cash flow risks.